1. Stocks
  2. Indo US Bio-Tech Ltd.
  3. Swot
swot-logo

Indo US Bio-Tech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Indo US Bio-Tech Ltd. has 12 Strengths, 15 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Mid-range Performer (DVM)

Company with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with Low Debt

Increasing profits every quarter for the past 3 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Company with Zero Promoter Pledge

Companies with growing costs YoY for long term projects

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Increasing Trend in Non-Core Income

RSI indicating price weakness

Highest fall from 52 Week High

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Bullish or Bearish Candlestick Strength - Indices

Inverted Hammer (Bullish Reversal)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

New 52 Week Low